The reduction of infarct volume in the cyclosporine compared with the control group was overall not significant ( 21.8 mL [ interquartile range , IQR 5.1 , 69.2 mL ] vs 28.8 mL [ IQR 7.7 , 95.0 mL ] , respectively ; p = 0.18 ) .